Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$0.12 - $1.31 $1,852 - $20,225
15,439 Added 130.67%
27,254 $19,000
Q2 2022

Aug 11, 2022

BUY
$0.81 - $2.53 $9,570 - $29,891
11,815 New
11,815 $10,000
Q1 2022

May 12, 2022

SELL
$2.53 - $3.9 $70,999 - $109,445
-28,063 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$3.27 - $6.38 $178,865 - $348,979
-54,699 Reduced 66.09%
28,063 $109,000
Q3 2021

Nov 12, 2021

BUY
$5.11 - $10.81 $422,913 - $894,657
82,762 New
82,762 $448,000

About 180 Life Sciences Corp.


  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $70.5M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.